Sygnarowicz Krzysztof MD is categorized under Internal Medicine Practitioners in Copiague, NY and active since 1991.
Sygnarowicz Krzysztof MD was established in 1991, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Krzysztof Sygnarowicz at the company’s single location by writing to 5 Cedar Court, Copiague, New York NY 11726 or by phoning (631) 789-4187. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sygnarowicz Krzysztof MD |
| Contact Person: | Krzysztof Sygnarowicz |
| Address: | 5 Cedar Court, Copiague, New York 11726 |
| Phone Number: | (631) 789-4187 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Sygnarowicz Krzysztof MD was started in 1991 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Krzysztof Sygnarowicz for inquiries that concern Sygnarowicz Krzysztof MD by calling the company number (631) 789-4187, as your correspondence is most welcome. Additionally, the physical location of the single location of Sygnarowicz Krzysztof MD can be found at the coordinates 40.669838,-73.393191 as well as the street address 5 Cedar Court in Copiague, New York 11726.
For its online presence, you may visit Sygnarowicz Krzysztof MD’s website at and engage with its social media outlets through on Twitter and on Facebook.